Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_2022_dividend_payment_espi_90.pdf "Sopharma" AD starts the payment of the 2022 dividend on July 31, 2023

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 90 / 2023
Date of issue: 2023-07-26
Short name of the issuer
SOPHARMA AD
Subject
"Sopharma" AD starts the payment of the 2022 dividend on July 31, 2023
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that on July 31, 2023 the Company will initiate the payment of the 2022 dividend of 60 stotinki voted on the Annual General Meeting of Shareholders held on June 2, 2023.

The shareholders eligible for dividend are those registered in the book of shareholders 14 days after the date of the GMS on which the distribution of dividend was voted, i.e. June 16, 2023.

In accordance with the Regulations of the Central Depository, the dividend shall be paid out as follows: for shareholders with client accounts at an investment intermediary – through the respective investment intermediary, for shareholders with personal accounts at the “Central Depository” AD - through the branches of “Eurobank Bulgaria” AD /Postbank/ in the country.
Annexes
File Description
SFA_2022_dividend_payment_espi_90.pdf
SFA_2022_dividend_payment_espi_90.pdf
"Sopharma" AD starts the payment of the 2022 dividend on July 31, 2023

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-07-26 Ognian Donev Executive Director
20230726_130353_1891891109_SFA_2022_dividend_payment_espi_90.pdf